AU2002328905A1 - A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method - Google Patents
A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the methodInfo
- Publication number
- AU2002328905A1 AU2002328905A1 AU2002328905A AU2002328905A AU2002328905A1 AU 2002328905 A1 AU2002328905 A1 AU 2002328905A1 AU 2002328905 A AU2002328905 A AU 2002328905A AU 2002328905 A AU2002328905 A AU 2002328905A AU 2002328905 A1 AU2002328905 A1 AU 2002328905A1
- Authority
- AU
- Australia
- Prior art keywords
- microphysiometer
- substance
- determining
- therapeutic effectiveness
- effectiveness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000126 substance Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10134446.5 | 2001-07-16 | ||
| DE10134446 | 2001-07-16 | ||
| PCT/EP2002/007910 WO2003008530A2 (fr) | 2001-07-16 | 2002-07-16 | Technique de determination de l'efficacite therapeutique d'une substance au moyen d'un dispositif de micromesure biometrique et utilisation de cette technique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002328905A1 true AU2002328905A1 (en) | 2003-03-03 |
Family
ID=7691906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002328905A Abandoned AU2002328905A1 (en) | 2001-07-16 | 2002-07-16 | A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002328905A1 (fr) |
| WO (1) | WO2003008530A2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130330761A1 (en) * | 2012-06-12 | 2013-12-12 | Celcuity, LLC | Whole cell assays and methods |
| WO2015089380A2 (fr) | 2013-12-12 | 2015-06-18 | Celcuity Llc | Tests et procédés pour déterminer la sensibilité d'un sujet individuel à un agent thérapeutique |
| EP3879269A3 (fr) | 2017-03-20 | 2021-11-17 | Celcuity Inc. | Méthodes de mesure de l'activité d'une voie de signalisation pour la sélection d'agents thérapeutiques |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5860917A (en) * | 1997-01-15 | 1999-01-19 | Chiron Corporation | Method and apparatus for predicting therapeutic outcomes |
-
2002
- 2002-07-16 WO PCT/EP2002/007910 patent/WO2003008530A2/fr not_active Ceased
- 2002-07-16 AU AU2002328905A patent/AU2002328905A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003008530A2 (fr) | 2003-01-30 |
| WO2003008530A3 (fr) | 2003-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002330041A1 (en) | Method and device for the iontophoretic delivery of a drug | |
| GB0111872D0 (en) | Therapeutic agents and methods | |
| AU2002326600A1 (en) | Side-exit catheter and method for its use | |
| AU2003261251A1 (en) | Methods of delivering therapeutic agents | |
| AU2002234021A1 (en) | Method and device for the treatment of vulnerable tissue site | |
| AU2003261100A1 (en) | Devices delivering therapeutic agents and methods regarding the same | |
| AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
| AU2001256373A1 (en) | Syringe and method for the use thereof | |
| PL369288A1 (en) | Catheter and use method thereof | |
| GB0119025D0 (en) | Compounds and their therapeutic use | |
| AU2003237657A1 (en) | Means and methods for improved treatment using "setrones" | |
| AU2002363800A1 (en) | Therapeutic agent composition and method of use | |
| AU2002328905A1 (en) | A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method | |
| AUPQ582400A0 (en) | A method of treatment and agents for use therein | |
| AU2002360696A1 (en) | Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis | |
| AU2566201A (en) | Compounds and methods for the treatment of pain | |
| AU2002351798A1 (en) | Methods and dosage forms for improving the bioavailability of therapeutic agents | |
| AU2002234606A1 (en) | A system and a method for monitoring the effectiveness of a medical treatment | |
| AU2420201A (en) | Compounds and methods for the treatment of pain | |
| IL150208A0 (en) | Compound and method for the treatment of pain | |
| GB2376943B (en) | Compounds and their therapeutic use | |
| AU2002232563A1 (en) | Compounds for therapy and diagnosis and methods for using same | |
| GB0112237D0 (en) | Compounds and their therapeutic use | |
| AU2003293581A1 (en) | Method of identifying therapeutic agents | |
| AU2003213349A1 (en) | Therapeutic agent for pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |